Koers Aevi Genomic Medicine, LLC London S.E.

Aandelen

Vertraagde tijd London S.E. Andere beurzen			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
- ^GBX	-.--%		-7,63%	-.--%

Duur

Periode

Stijl

Medgenics, Inc. : Medgenics Receives Orphan Drug Designation from FDA for INFRADURE Biopump to Treat Hepatitis D	20-06-12
Medgenics, Inc. : Medgenics to Present at the 11th Annual ILSI BIOMED 2012	18-05-12
Medgenics, Inc. : Medgenics Announces First Quarter 2012 Financial Results	14-05-12
Medgenics, Inc. : Medgenics Awarded $2.2 Million Grant from the Israeli Office of the Chief Scientist	09-05-12
Medgenics, Inc. : Medgenics Comments on Market Trading Activity	26-04-12

Sector